Header Logo

Connection

Richard Grant to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications Richard Grant has written about Diabetes Mellitus, Type 2.
Richard Grant
Connection Strength
11.054
Diabetes Mellitus, Type 2
  1. All in the Family: A Qualitative Study of the Early Experiences of Adults with Younger Onset Type 2 Diabetes. J Am Board Fam Med. 2022 Mar-Apr; 35(2):341-351.
    View in: PubMed
    Score: 0.475
  2. Disclosure of New Type 2 Diabetes Diagnoses to Younger Adults: a Qualitative Study. J Gen Intern Med. 2021 06; 36(6):1622-1628.
    View in: PubMed
    Score: 0.440
  3. Initial Glycemic Control and Care Among Younger Adults Diagnosed With Type 2 Diabetes. Diabetes Care. 2020 05; 43(5):975-981.
    View in: PubMed
    Score: 0.414
  4. Use and Discontinuation of Insulin Treatment Among Adults Aged 75 to 79 Years With Type 2 Diabetes. JAMA Intern Med. 2019 12 01; 179(12):1633-1641.
    View in: PubMed
    Score: 0.407
  5. Prevalence and predictors of delayed clinical diagnosis of Type 2 diabetes: a longitudinal cohort study. Diabet Med. 2018 12; 35(12):1655-1662.
    View in: PubMed
    Score: 0.374
  6. Primary care visit preparation and communication for patients with poorly controlled diabetes: A qualitative study of patients and physicians. Prim Care Diabetes. 2017 04; 11(2):148-153.
    View in: PubMed
    Score: 0.330
  7. Pre-Visit Prioritization for complex patients with diabetes: Randomized trial design and implementation within an integrated health care system. Contemp Clin Trials. 2016 Mar; 47:196-201.
    View in: PubMed
    Score: 0.311
  8. Changes in physical activity among adults with diabetes: a longitudinal cohort study of inactive patients with Type 2 diabetes who become physically active. Diabet Med. 2015 Aug; 32(8):1051-7.
    View in: PubMed
    Score: 0.295
  9. Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
    View in: PubMed
    Score: 0.291
  10. Intensification of diabetes medication and risk for 30-day readmission. Diabet Med. 2013 Feb; 30(2):e56-62.
    View in: PubMed
    Score: 0.253
  11. Lower blood pressure associated with higher mortality in retrospective study of patients with newly diagnosed type 2 diabetes. Evid Based Med. 2013 Aug; 18(4):e35.
    View in: PubMed
    Score: 0.250
  12. Genetic counseling as a tool for type 2 diabetes prevention: a genetic counseling framework for common polygenetic disorders. J Genet Couns. 2012 Oct; 21(5):684-91.
    View in: PubMed
    Score: 0.247
  13. Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. Diabetes Care. 2013 Jan; 36(1):13-9.
    View in: PubMed
    Score: 0.246
  14. Characteristics of "complex" patients with type 2 diabetes mellitus according to their primary care physicians. Arch Intern Med. 2012 May 28; 172(10):821-3.
    View in: PubMed
    Score: 0.242
  15. Impact of literacy and numeracy on motivation for behavior change after diabetes genetic risk testing. Med Decis Making. 2012 Jul-Aug; 32(4):606-15.
    View in: PubMed
    Score: 0.235
  16. Design of a randomized trial of diabetes genetic risk testing to motivate behavior change: the Genetic Counseling/lifestyle Change (GC/LC) Study for Diabetes Prevention. Clin Trials. 2011 Oct; 8(5):609-15.
    View in: PubMed
    Score: 0.231
  17. Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes. Diabetes Care. 2011 Mar; 34(3):568-73.
    View in: PubMed
    Score: 0.220
  18. Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines. Diabetes Educ. 2011 Jan-Feb; 37(1):78-84.
    View in: PubMed
    Score: 0.218
  19. Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study. BMC Health Serv Res. 2010 Jun 09; 10:158.
    View in: PubMed
    Score: 0.211
  20. Loss-of-function CYP2C9 variants: finding the correct clinical role for Type 2 diabetes pharmacogenetic testing. Expert Rev Cardiovasc Ther. 2010 Mar; 8(3):339-43.
    View in: PubMed
    Score: 0.207
  21. Mobile phone technology for children with type 1 and type 2 diabetes: a parent survey. J Diabetes Sci Technol. 2009 Nov 01; 3(6):1481-9.
    View in: PubMed
    Score: 0.202
  22. The clinical application of genetic testing in type 2 diabetes: a patient and physician survey. Diabetologia. 2009 Nov; 52(11):2299-2305.
    View in: PubMed
    Score: 0.200
  23. The decision to intensify therapy in patients with type 2 diabetes: results from an experiment using a clinical case vignette. J Am Board Fam Med. 2009 Sep-Oct; 22(5):513-20.
    View in: PubMed
    Score: 0.200
  24. Genetic architecture of type 2 diabetes: recent progress and clinical implications. Diabetes Care. 2009 Jun; 32(6):1107-14.
    View in: PubMed
    Score: 0.196
  25. Diabetes connected health: a pilot study of a patient- and provider-shared glucose monitoring web application. J Diabetes Sci Technol. 2009 Mar 01; 3(2):345-52.
    View in: PubMed
    Score: 0.193
  26. Practice-linked online personal health records for type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med. 2008 Sep 08; 168(16):1776-82.
    View in: PubMed
    Score: 0.187
  27. Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabet Med. 2008 Sep; 25(9):1102-7.
    View in: PubMed
    Score: 0.186
  28. Differentiating symptoms of depression from diabetes-specific distress: relationships with self-care in type 2 diabetes. Diabetologia. 2008 Oct; 51(10):1822-5.
    View in: PubMed
    Score: 0.186
  29. Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%. Diabetes Care. 2008 Mar; 31(3):386-90.
    View in: PubMed
    Score: 0.177
  30. Invited commentary: untangling the web of diabetes causality in African Americans. Am J Epidemiol. 2007 Aug 15; 166(4):388-90; discussion 391-2.
    View in: PubMed
    Score: 0.172
  31. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care. 2007 Sep; 30(9):2222-7.
    View in: PubMed
    Score: 0.171
  32. How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. Diabetes Care. 2007 Jun; 30(6):1448-53.
    View in: PubMed
    Score: 0.168
  33. Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction. Diabetes Care. 2007 Mar; 30(3):479-84.
    View in: PubMed
    Score: 0.168
  34. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007 Apr; 30(4):807-12.
    View in: PubMed
    Score: 0.167
  35. Internet use among primary care patients with type 2 diabetes: the generation and education gap. J Gen Intern Med. 2005 May; 20(5):470-3.
    View in: PubMed
    Score: 0.148
  36. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care. 2005 Feb; 28(2):337-442.
    View in: PubMed
    Score: 0.145
  37. A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes Care. 2004 Oct; 27(10):2299-305.
    View in: PubMed
    Score: 0.142
  38. Rationale and design of the KP ENRICH trial: A food is medicine intervention in low-income high-risk adults with diabetes within Kaiser Permanente. Contemp Clin Trials. 2024 Aug; 143:107601.
    View in: PubMed
    Score: 0.139
  39. Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med. 2004 Feb; 21(2):150-5.
    View in: PubMed
    Score: 0.136
  40. Should the insulin resistance syndrome be treated in the elderly? Drugs Aging. 2004; 21(3):141-51.
    View in: PubMed
    Score: 0.135
  41. Impact of population management with direct physician feedback on care of patients with type 2 diabetes. Diabetes Care. 2003 Aug; 26(8):2275-80.
    View in: PubMed
    Score: 0.131
  42. Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother. 2003 Jul-Aug; 37(7-8):962-9.
    View in: PubMed
    Score: 0.130
  43. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003 May; 26(5):1408-12.
    View in: PubMed
    Score: 0.129
  44. Associations between alcohol brief intervention in primary care and drinking and health outcomes in adults with hypertension and type 2 diabetes: a population-based observational study. BMJ Open. 2023 01 19; 13(1):e064088.
    View in: PubMed
    Score: 0.126
  45. Address Changes Are Associated With Unmet Glycemic Targets: Opportunities to Improve Processes and Outcomes of Care Among People With Type 2 Diabetes. Perm J. 2022 06 29; 26(2):1-10.
    View in: PubMed
    Score: 0.121
  46. Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. Am J Med. 2002 Jun 01; 112(8):603-9.
    View in: PubMed
    Score: 0.121
  47. Association of Anxiety With High-Cost Health Care Use Among Individuals With Type 2 Diabetes. Diabetes Care. 2019 09; 42(9):1669-1674.
    View in: PubMed
    Score: 0.098
  48. Association of Patient-Physician Language Concordance and Glycemic Control for Limited-English Proficiency Latinos With Type 2 Diabetes. JAMA Intern Med. 2017 03 01; 177(3):380-387.
    View in: PubMed
    Score: 0.084
  49. Association of Acculturation and Health Literacy with Prevalent Dysglycemia and Diabetes Control Among Latinos in the Boston Area Community Health (BACH) Survey. J Immigr Minor Health. 2016 12; 18(6):1266-1273.
    View in: PubMed
    Score: 0.083
  50. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes. PLoS One. 2015; 10(3):e0121553.
    View in: PubMed
    Score: 0.073
  51. Individualizing HbA1c targets for patients with diabetes: impact of an automated algorithm within a primary care network. Diabet Med. 2014 Jul; 31(7):839-46.
    View in: PubMed
    Score: 0.069
  52. Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus. Metabolism. 2013 Dec; 62(12):1772-8.
    View in: PubMed
    Score: 0.066
  53. Effect of hospital admission on glycemic control 1 year after discharge. Endocr Pract. 2012 Jul-Aug; 18(4):456-63.
    View in: PubMed
    Score: 0.061
  54. Implementing a web-based home monitoring system within an academic health care network: barriers and facilitators to innovation diffusion. J Diabetes Sci Technol. 2011 Jan 01; 5(1):32-8.
    View in: PubMed
    Score: 0.055
  55. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care. 2011 Jan; 34(1):121-5.
    View in: PubMed
    Score: 0.054
  56. Survey analysis of patient experience using a practice-linked PHR for type 2 diabetes mellitus. AMIA Annu Symp Proc. 2009 Nov 14; 2009:678-82.
    View in: PubMed
    Score: 0.051
  57. Medication adherence and racial differences in A1C control. Diabetes Care. 2008 May; 31(5):916-21.
    View in: PubMed
    Score: 0.045
  58. Reevaluating the digital divide: current lack of internet use is not a barrier to adoption of novel health information technology. Diabetes Care. 2008 Mar; 31(3):433-5.
    View in: PubMed
    Score: 0.044
  59. Association of diabetes-related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes. Diabet Med. 2007 Jan; 24(1):48-54.
    View in: PubMed
    Score: 0.042
  60. The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients. Curr Med Res Opin. 2006 Nov; 22(11):2301-11.
    View in: PubMed
    Score: 0.041
  61. Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006 Jul; 49(7):1489-97.
    View in: PubMed
    Score: 0.040
  62. Cost of an informatics-based diabetes management program. Int J Technol Assess Health Care. 2006; 22(2):249-54.
    View in: PubMed
    Score: 0.039
  63. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care. 2005 Mar; 28(3):514-20.
    View in: PubMed
    Score: 0.037

© 2024 Kaiser Permanente